NYSE:CLB - New York Stock Exchange, Inc. - US21867A1051 - Common Stock - Currency: USD
14.85
+0.76 (+5.39%)
The current stock price of CLB is 14.85 USD. In the past month the price decreased by -11.08%. In the past year, price decreased by -6.84%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
SLB | SCHLUMBERGER LTD | 12.13 | 56.26B | ||
BKR | BAKER HUGHES CO | 18.1 | 42.47B | ||
HAL | HALLIBURTON CO | 8.36 | 21.70B | ||
TS | TENARIS SA-ADR | 8.04 | 19.96B | ||
FTI | TECHNIPFMC PLC | 14.57 | 11.22B | ||
NOV | NOV INC | 9.29 | 5.70B | ||
CHX | CHAMPIONX CORP | 16.39 | 5.66B | ||
AROC | ARCHROCK INC | 22.54 | 4.15B | ||
WFRD | WEATHERFORD INTERNATIONAL PL | 8.35 | 4.09B | ||
WHD | CACTUS INC - A | 15.58 | 3.77B | ||
KGS | KODIAK GAS SERVICES INC | 39.17 | 2.99B | ||
USAC | USA COMPRESSION PARTNERS LP | 32.99 | 2.99B |
Core Laboratories, Inc. provides proprietary and patented reservoir description and production enhancement services. The company is headquartered in Houston, Texas and currently employs 3,600 full-time employees. The company went IPO on 2018-10-22. The firm helps to evaluate and improve reservoir performance and increase oil and gas recovery from new and existing fields. The company makes measurements of reservoir rocks, reservoir fluids (crude oil, natural gas and water) and their derived products. In addition, the Company assists clients in evaluating subsurface targets associated with carbon capture and sequestration projects or initiatives. The firm has two segments. Reservoir Description segment provides laboratory-based analytical and field services to characterize the properties of crude oil and crude oil-derived products for the oil and gas industry. In addition, it provides reservoir description capabilities. Production Enhancement segment provides integrated diagnostic services. The firm has approximately 70 offices in more than 50 countries.
CORE LABORATORIES INC
6316 Windfern Road
Houston TEXAS 1077 XX US
CEO: Lawrence Bruno
Employees: 3500
Company Website: https://www.corelab.com/
Investor Relations: https://www.corelab.com/investors
Phone: 17133282673
The current stock price of CLB is 14.85 USD. The price increased by 5.39% in the last trading session.
The exchange symbol of CORE LABORATORIES INC is CLB and it is listed on the New York Stock Exchange, Inc. exchange.
CLB stock is listed on the New York Stock Exchange, Inc. exchange.
12 analysts have analysed CLB and the average price target is 19.38 USD. This implies a price increase of 30.51% is expected in the next year compared to the current price of 14.85. Check the CORE LABORATORIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
CORE LABORATORIES INC (CLB) has a market capitalization of 695.43M USD. This makes CLB a Small Cap stock.
CORE LABORATORIES INC (CLB) currently has 3500 employees.
CORE LABORATORIES INC (CLB) has a support level at 14.64 and a resistance level at 15.88. Check the full technical report for a detailed analysis of CLB support and resistance levels.
The Revenue of CORE LABORATORIES INC (CLB) is expected to grow by 4.2% in the next year. Check the estimates tab for more information on the CLB EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
CORE LABORATORIES INC (CLB) has a dividend yield of 0.28%. The yearly dividend amount is currently 0.04. Check the full fundamental report for a detailed analysis of CLB dividend history, reliability and sustainability.
The PE ratio for CORE LABORATORIES INC (CLB) is 16.88. This is based on the reported non-GAAP earnings per share of 0.88 and the current share price of 14.85 USD. Check the full fundamental report for a full analysis of the valuation metrics for CLB.
The outstanding short interest for CORE LABORATORIES INC (CLB) is 13.07% of its float. Check the ownership tab for more information on the CLB short interest.
ChartMill assigns a fundamental rating of 5 / 10 to CLB. CLB has only an average score on both its financial health and profitability.
Over the last trailing twelve months CLB reported a non-GAAP Earnings per Share(EPS) of 0.88. The EPS increased by 8.64% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 5.99% | ||
ROA | 5.32% | ||
ROE | 12.46% | ||
Debt/Equity | 0.5 |
ChartMill assigns a Buy % Consensus number of 47% to CLB. The Buy consensus is the average rating of analysts ratings from 12 analysts.
For the next year, analysts expect an EPS growth of 4.19% and a revenue growth 4.2% for CLB